Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Novo Nordisk 14.911, Roche 17.1305.
* Roche reports semi-annually. Values are evenly split across both quarters within each half.
Novo Nordisk vs Roche Net Worth and Market Cap
Novo Nordisk (NVO) and Roche (RHHBY) are peers in GLP-1. Novo Nordisk reported revenue of $14.9B as of Q1 2026, compared with $34.3B for Roche. Roche leads on revenue.
Novo Nordisk's gross margin is 86.0% versus 71.7% for Roche. Novo Nordisk's net margin is 50.1% versus 17.9% for Roche.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Novo Nordisk, Roche.| Metric | Novo Nordisk | Roche |
|---|---|---|
| Market Cap | - | - |
| Revenue | $14.91B | $34.26B |
| Cost of Revenue | $2.09B | $9.68B |
| Gross Profit | $12.82B | $24.58B |
| Operating Income | $9.18B | $7.96B |
| Net Income | $7.48B | $6.13B |
| R&D Expense | $1.58B | $7.48B |
| Earnings Per Share | $1.68 | $0.95 |
| Gross Margin | 86.0% | 71.7% |
| Operating Margin | 61.6% | 23.2% |
| Net Profit Margin | 50.1% | 17.9% |
| Free Cash Flow | $1.85B | $10.67B |
| Cumulative Free Cash Flow | $100.86B | $299.34B |
| Operating Cash Flow | $3.71B | $13.12B |
| Cash & Equivalents | $3.25B | $6.32B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.